FDA Warning Letter — Hospira Australia Pty Ltd.

Case 432259 — FEI 3001174929

The FDA took a Warning Letter action against Hospira Australia Pty Ltd. on September 26, 2014 (Mulgrave, Australia). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Hospira Australia Pty Ltd.
Date
September 26, 2014
Fiscal Year
2014
Product Type
Drugs
Center
CDER
Location
Mulgrave (Australia)